The AD/PD™ Alzheimer’s disease and Parkinson’s disease Conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders. The groundbreaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference remains at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s, and other related neurodegenerative diseases. AD/PD™ Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention, and therapy.

The AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ is now an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

The forthcoming AD/PD™ meeting, in 2025 will take place as a Hybrid Conference in the enchanting city of Vienna, Austria, and online.